General Experimental Section

Reagents and instruments
All commercially available reagents were purchased from Sigma Aldrich, Alfa Aesar, Acros Organics or TCI and were used without further purification. Molecular sieves and aluminum oxide were dried for 3 days at 150 °C under reduced pressure (10 -2 mbar) before use. CDCl3 was dried for at least 3 days over molecular sieves. All solvents were dried over molecular sieves for at least 24 hours. All orthoester exchange reactions (catalyzed by TFA) were carried out under nitrogen. NMR spectra were recorded on Bruker Avance 400 or Bruker Avance 500 ( 1 H: 400 or 500 MHz) spectrometers at 298 K and referenced to the residual solvent peak ( 1 H: CDCl3, 7.26 ppm; CD3CN, 1.94 ppm, CD2Cl2: 5.32 ppm; 13 C: CDCl3, 77.0 ppm; CD3CN, 1.32 ppm, CD2Cl2: 53.84 ppm). Coupling constants (J) are denoted in Hz and chemical shifts (δ) in ppm. Mass spectra were obtained on a Bruker SolariX (HRMS-ESI + , Solvent: methanol or acetonitrile) instrument.
Lithium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate was synthesized according to literature procedures. 1 
General Procedures
General Procedure A (metal-templated cryptate syntheses):
Drying of starting materials: Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate or Lithium tetrakis[3,5bis(trifluoromethyl)phenyl]borate was dissolved in anhydrous acetonitrile, trimethyl orthoformate (1 mL per gram MBArF) and a catalytic amount of TFA were added. The solvent was removed under reduced pressure and the salt was dried under high vacuum. Diethylene glycol was dried and stored over 3 Å MS and aluminum oxide. Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (60 µmol, 1.0 equiv., 54 mg) or Lithium tetrakis[3,5bis(trifluoromethyl)phenyl]borate (60 µmol, 1.0 equiv., 52 mg), diethylene glycol (180 µmol, 3.0 equiv., 17.3 µL) and anhydrous trimethyl orthoformate (120 µmol, 2.0 equiv., 13.3 µL) were dissolved in anhydrous chloroform (6 mL) under inert atmosphere. TFA stock solution (1.2 µmol, 0.01 equiv., 10 µL) was added. After equilibration of the reaction mixture, 5 Å MS was added. The reaction progress was monitored by 1 H-NMR spectroscopy. If needed, more TFA stock solution was added. Upon completion, the reaction was quenched by addition of triethylamine and the solvent was removed under reduced pressure. The crude product was purified by passing it over a short plug of silica gel. The plug was rinsed with anhydrous chloroform and removal of the solvent under reduced pressure gave the corresponding salts as colourless solids.
General Procedure B (NMR titrations):
Stock solutions of cryptand and NaBArF in CDCl3 were prepared. The precise quantity of cryptand or metal salt was determined with 1,4-dinitrobenzene as internal standard. A cryptand stock solution with precise concentration was prepared via dilution. To the solution of metal salt, cryptand stock solution was added to keep the concentration of cryptand during the titration constant. 600 µL of cryptand stock solution were added to a standard NMR tube, varying amounts of metal salt stock solution were added. The titration was monitored by 1 H NMR spectroscopy (temperature: 298 K). Binding constants were fitted using Bindfit. All raw data, calculated fits and related data can be accessed via www.supramolecular.org.
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Synthetic Procedures and Characterization Data
Synthesis of Orthoester Cryptates
Synthesis of o-(Hin)2-1.1.1
Diethylene glycol (3.6 mmol, 3.0 equiv., 345 µL) and trimethyl orthoformate (2.4 mmol, 2.0 equiv., 265 µL) were dissolved in anhydrous chloroform (60 mL) under inert atmosphere. TFA (24 µmol, 0.01 equiv., 1.86 µL) was added. After equilibration of the reaction mixture, 5 Å MS was added. The reaction progress was monitored by 1 H-NMR spectroscopy. After 1 day more TFA (24 µmol, 0.01 equiv., 1.86 µL) was added. After 3 days in total the reaction was quenched by addition of triethylamine and the solvent was removed under reduced pressure. The crude product was purified by washing with diethyl ether to give o-(Hin)2-1.1.1 as crystalline solid (206 mg, 51%). -(H)2-1.1.1 cryptand to o-(Hin)2-1.1.1: o-(H)2-1.1.1 (6 µmol, 1 .0 equiv.) was dissolved in CHCl3 (6 mL), TFA stock solution (0.12 µmol, 0.01 equiv., 1 µL) was added. The reaction mixture was left standing without stirring for 10 min. The reaction was quenched by addition of triethylamine and the solvent was removed under reduced pressure to give the product as colourless solid. : o-(H)2-1.1.1 (60 µmol, 1 .0 equiv.) was stirred in CH3CN (6 mL) with sodium or lithium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (60 µmol, 1.0 equiv.) for 5 min. Removal of the solvent under reduced pressure gave the products as colourless solids.
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Experimental Binding Studies
The NMR titrations were carried out according to general procedure B. -(Hin)2-1.1.1 was crystallized by slow evaporation of a solution of o-(Hin)2-1.1.1 
